Eagle Asset Management Inc Amgen Inc Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Eagle Asset Management Inc holds 50,670 shares of AMGN stock, worth $14.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
50,670
Previous 73,090 30.67%
Holding current value
$14.9 Million
Previous $22.8 Million 28.51%
% of portfolio
0.1%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$309.38 - $337.38 $6.94 Million - $7.56 Million
-22,420 Reduced 30.67%
50,670 $16.3 Million
Q2 2024

Aug 12, 2024
BUY
$262.75 - $319.31 $344,728 - $418,934
1,312 Added 1.83%
73,090 $22.8 Million
Q1 2024

May 09, 2024
SELL
$268.87 - $324.56 $111 Million - $134 Million
-412,053 Reduced 85.16%
71,778 $20.4 Million
Q4 2023

Feb 12, 2024
BUY
$255.7 - $288.46 $32.3 Million - $36.5 Million
126,503 Added 35.4%
483,831 $139 Million
Q3 2023

Nov 13, 2023
BUY
$218.65 - $271.46 $67.6 Million - $83.9 Million
309,234 Added 642.98%
357,328 $96 Million
Q2 2023

Aug 09, 2023
BUY
$214.27 - $253.37 $103,278 - $122,124
482 Added 1.01%
48,094 $10.7 Million
Q1 2023

May 08, 2023
BUY
$225.79 - $275.2 $160,536 - $195,667
711 Added 1.52%
47,612 $11.5 Million
Q4 2022

Feb 14, 2023
BUY
$229.03 - $291.01 $23,361 - $29,683
102 Added 0.22%
46,901 $12.3 Million
Q1 2022

May 12, 2022
SELL
$219.27 - $242.57 $56,133 - $62,097
-256 Reduced 0.54%
46,799 $11.3 Million
Q4 2021

Feb 11, 2022
BUY
$198.88 - $227.6 $49,720 - $56,900
250 Added 0.53%
47,055 $10.7 Million
Q3 2021

Nov 10, 2021
BUY
$212.27 - $248.7 $12,311 - $14,424
58 Added 0.12%
46,805 $9.95 Million
Q2 2021

Aug 11, 2021
SELL
$233.58 - $259.14 $2.73 Million - $3.03 Million
-11,687 Reduced 20.0%
46,747 $11.4 Million
Q1 2021

May 14, 2021
BUY
$221.91 - $258.6 $1.72 Million - $2 Million
7,733 Added 15.25%
58,434 $14.6 Million
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $78 Million - $92.9 Million
-360,413 Reduced 87.67%
50,701 $11.7 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $58.3 Million - $64.8 Million
248,377 Added 152.62%
411,114 $102 Million
Q2 2020

Aug 12, 2020
BUY
$197.81 - $242.74 $3.61 Million - $4.44 Million
18,275 Added 12.65%
162,737 $37.7 Million
Q1 2020

May 11, 2020
BUY
$182.24 - $241.7 $21.8 Million - $28.9 Million
119,755 Added 484.7%
144,462 $29.3 Million
Q4 2019

Feb 07, 2020
BUY
$189.21 - $243.2 $1.14 Million - $1.47 Million
6,029 Added 32.28%
24,707 $5.96 Million
Q3 2019

Nov 04, 2019
BUY
$174.11 - $208.62 $158,614 - $190,052
911 Added 5.13%
18,678 $3.61 Million
Q2 2019

Aug 05, 2019
BUY
$166.7 - $195.41 $136,527 - $160,040
819 Added 4.83%
17,767 $3.27 Million
Q1 2019

May 01, 2019
SELL
$180.87 - $203.88 $2.34 Million - $2.64 Million
-12,956 Reduced 43.33%
16,948 $3.22 Million
Q4 2018

Feb 11, 2019
SELL
$178.4 - $208.25 $89,913 - $104,958
-504 Reduced 1.66%
29,904 $5.82 Million
Q3 2018

Nov 08, 2018
BUY
$185.29 - $208.89 $138,226 - $155,831
746 Added 2.52%
30,408 $6.3 Million
Q2 2018

Aug 07, 2018
BUY
$166.05 - $186.51 $81,862 - $91,949
493 Added 1.69%
29,662 $5.48 Million
Q1 2018

May 09, 2018
BUY
$169.43 - $198.0 $16,434 - $19,206
97 Added 0.33%
29,169 $4.97 Million
Q4 2017

Feb 09, 2018
SELL
$168.79 - $188.59 $8,101 - $9,052
-48 Reduced 0.16%
29,072 $5.13 Million
Q3 2017

Nov 09, 2017
BUY
$167.29 - $191.0 $4.87 Million - $5.56 Million
29,120
29,120 $5.45 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email